These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9686927)

  • 1. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy.
    Hounsom L; Horrobin DF; Tritschler H; Corder R; Tomlinson DR
    Diabetologia; 1998 Jul; 41(7):839-43. PubMed ID: 9686927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy.
    Hounsom L; Corder R; Patel J; Tomlinson DR
    Diabetologia; 2001 Apr; 44(4):424-8. PubMed ID: 11357471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
    Cameron NE; Cotter MA
    Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions.
    Ayaz M; Tuncer S; Okudan N; Gokbel H
    Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):367-74. PubMed ID: 18806896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids.
    Cameron NE; Cotter MA; Horrobin DH; Tritschler HJ
    Diabetologia; 1998 Apr; 41(4):390-9. PubMed ID: 9562342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilazapril and dietary gamma-linolenic acid prevent the deficit in sciatic nerve conduction velocity in the streptozotocin diabetic rat.
    Burnard SL; McMurchie EJ; Leifert WR; Patten GS; Muggli R; Raederstorff D; Head RJ
    J Diabetes Complications; 1998; 12(2):65-73. PubMed ID: 9559483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.
    Dines KC; Cotter MA; Cameron NE
    Diabetologia; 1993 Nov; 36(11):1132-8. PubMed ID: 8270127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At low doses, a gamma-linolenic acid-lipoic acid conjugate is more effective than docosahexaenoic acid-enriched phospholipids in preventing neuropathy in diabetic rats.
    Pitel S; Raccah D; Gerbi A; Pieroni G; Vague P; Coste TC
    J Nutr; 2007 Feb; 137(2):368-72. PubMed ID: 17237313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M; Omawari N; Tomlinson DR
    Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats.
    Hanaoka Y; Ohi T; Furukawa S; Furukawa Y; Hayashi K; Matsukura S
    Exp Neurol; 1992 Feb; 115(2):292-6. PubMed ID: 1735473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of gamma-linolenic acid-alpha-lipoic acid conjugate in streptozotocin diabetic rats.
    Khamaisi M; Rudich A; Beeri I; Pessler D; Friger M; Gavrilov V; Tritschler H; Bashan N
    Antioxid Redox Signal; 1999; 1(4):523-35. PubMed ID: 11233149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
    Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
    Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
    Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
    Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Maxfield EK
    Diabetologia; 1993 Apr; 36(4):299-304. PubMed ID: 8477873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats.
    Bravenboer B; Kappelle AC; van Buren T; Erkelens DW; Gispen WH
    Acta Diabetol; 1993; 30(1):21-4. PubMed ID: 8392402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ; Smale S; Duis SE; Kamal A; Gispen WH
    J Neurol Sci; 2001 Jan; 182(2):99-106. PubMed ID: 11137514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Sakata Y; Muto G; Muto Y; Takahashi K; Toyota T
    Diabetologia; 1998 Nov; 41(11):1321-6. PubMed ID: 9833940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathy in a rat model of mild diabetes induced by multiple low doses of streptozotocin: effects of the antioxidant stobadine in comparison with a high-dose alpha-lipoic acid treatment.
    Skalská S; Kucera P; Goldenberg Z; Stefek M; Kyselová Z; Jariabka P; Gajdosíková A; Klobucníková K; Traubner P; Stolc S
    Gen Physiol Biophys; 2010 Mar; 29(1):50-8. PubMed ID: 20371880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.